Related Experiment Videos
Toxicologic studies of dihydro-5,6-dehydrokawain and 5,6-dehydrokawain
Planta Medica
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
WT1 Inhibits Human Renal Carcinoma Cell Proliferation and Induces G2/M Arrest by Upregulating IL-24 Expression.
BioMed research international·2022
[Energy metabolism characteristic with risk of secondary bacterial infection in patients with hepatitis B virus-related chronic liver disease].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2021
Unusual Near-Horizon Cosmic-Ray-like Events Observed by ANITA-IV.
Physical review letters·2021
Oral health knowledge and practices in the Kaski District of Nepal.
Community dental health·2021
[Covered airway stent loaded with (125)I seeds for tracheal adenoid cystic carcinoma: a clinical observation of 8 cases].
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2020
[Effect of overexpression of apoptosis-stimulating protein 2 of p53 on activation and apoptosis of hepatic stellate cells induced by transforming growth factor-β1 and its mechanism].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2020
Biotinylated ε-Polylysine-Cyclodextrin-Coated Mesoporous Silica Nanoparticles for Targeted pH-Responsive Baicalin Delivery.
International journal of nanomedicine·2026
Binding of Epimedium Flavonoids to Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies.
Iranian journal of pharmaceutical research : IJPR·2026
Fluorescence-based assay for evaluating SLC49A4 function: Identification of acriflavine as a probe substrate.
Journal of pharmaceutical sciences·2026
Use of cannabidiol products in Canada, United States, Australia, Aotearoa New Zealand, United Kingdom and Germany: products, sources and reasons for use.
The International journal on drug policy·2026